Literature DB >> 8965133

Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy.

P R Franken1, P Dendale, F De Geeter, D Demoor, A Bossuyt, P Block.   

Abstract

UNLABELLED: We determined the predictive value of combined beta-methyl iodophenyl pentadecanoic acid (BMIPP) and sestamibi scintigraphy for the functional outcome after myocardial infarction and compared the value of this approach with dobutamine echocardiography.
METHODS: Rest BMIPP, rest sestamibi and low-dose dobutamine echocardiographic studies were obtained in 18 patients 4 to 10 days after infarction (mean 6.7 +/- 2.0 days). Six months later, a rest echocardiographic study was performed to assess functional outcome.
RESULTS: Wall motion improved in 27/33 segments (82%) which showed mismatching but not in 19/21 segments (90%) with matched defects (p < 0.001). The accuracy of combined BMIPP and sestamibi SPECT in predicting segmental functional outcome was higher (85%) than that of sestamibi uptake alone (77%). Wall motion improved in 16/20 segments (80%) showing contractile reserve and not in 21/34 segments (63%) with the negative dobutamine test, giving an accuracy of 69% for dobutamine echocardiography. Combination of the two techniques resulted in higher positive (94%) and negative predictive values (94%).
CONCLUSION: Mismatching of BMIPP and sestamibi uptake is predictive for long-term functional recovery after acute myocardial infarction. In contrast, segments with matched defects contain only scar tissue. Combined BMIPP and sestamibi scintigraphy offers increased accuracy compared to dobutamine echocardiography.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8965133

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  20 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

2.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

3.  Perfusion-BMIPP mismatch: specific finding or artifact?

Authors:  Koichi Morita; Eriko Tsukamoto; Nagara Tamaki
Journal:  Int J Cardiovasc Imaging       Date:  2002-08       Impact factor: 2.357

Review 4.  Diagnostic and prognostic value of BMIPP imaging.

Authors:  Taishiro Chikamori; Akira Yamashina; Satoshi Hida; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2007-01       Impact factor: 5.952

Review 5.  Future directions of myocardial fatty acid imaging.

Authors:  Christopher J Pastore; John W Babich; James E Udelson
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

Review 6.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

7.  Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch.

Authors:  S Fujiwara; Y Takeishi; H Atsumi; M Yamaki; N Takahashi; M Yamaoka; T Tojo; H Tomoike
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

Review 8.  Cardiac BMIPP imaging in acute myocardial infarction.

Authors:  T Nakata; A Hashimoto; M Eguchi
Journal:  Int J Card Imaging       Date:  1999-02

Review 9.  BMIPP compared with thallium redistribution.

Authors:  J Taki; I Matsunari; K Nakajima; N Tonami
Journal:  Int J Card Imaging       Date:  1999-02

Review 10.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.